KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Merck (MRK) Other Operating Expenses (2016 - 2025)

Merck (MRK) has disclosed Other Operating Expenses for 16 consecutive years, with $9.7 billion as the latest value for Q4 2025.

  • On a quarterly basis, Other Operating Expenses rose 145.74% to $9.7 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $20.3 billion, a 33.62% increase, with the full-year FY2025 number at $16.5 billion, up 8.99% from a year prior.
  • Other Operating Expenses was $9.7 billion for Q4 2025 at Merck, up from $3.6 billion in the prior quarter.
  • In the past five years, Other Operating Expenses ranged from a high of $9.7 billion in Q4 2025 to a low of $2.7 billion in Q1 2021.
  • A 5-year average of $4.5 billion and a median of $3.9 billion in 2024 define the central range for Other Operating Expenses.
  • Peak YoY movement for Other Operating Expenses: plummeted 51.28% in 2024, then soared 145.74% in 2025.
  • Merck's Other Operating Expenses stood at $6.6 billion in 2021, then plummeted by 42.39% to $3.8 billion in 2022, then skyrocketed by 113.29% to $8.1 billion in 2023, then tumbled by 51.28% to $4.0 billion in 2024, then skyrocketed by 145.74% to $9.7 billion in 2025.
  • Per Business Quant, the three most recent readings for MRK's Other Operating Expenses are $9.7 billion (Q4 2025), $3.6 billion (Q3 2025), and $3.6 billion (Q2 2025).